- Home
- LMAT vs MLCO Comparison
LMAT vs MLCO Comparison
Compare LMAT & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMAT
- MLCO
- Stock Information
- Founded
- LMAT 1983
- MLCO 2004
- Country
- LMAT United States
- MLCO Hong Kong
- Employees
- LMAT N/A
- MLCO N/A
- Industry
- LMAT Medical/Dental Instruments
- MLCO Hotels/Resorts
- Sector
- LMAT Health Care
- MLCO Consumer Discretionary
- Exchange
- LMAT Nasdaq
- MLCO Nasdaq
- Market Cap
- LMAT 1.9B
- MLCO N/A
- IPO Year
- LMAT 2006
- MLCO 2006
- Fundamental
- Price
- LMAT $80.26
- MLCO $5.99
- Analyst Decision
- LMAT Buy
- MLCO Buy
- Analyst Count
- LMAT 7
- MLCO 5
- Target Price
- LMAT $100.67
- MLCO $7.24
- AVG Volume (30 Days)
- LMAT 187.8K
- MLCO 5.3M
- Earning Date
- LMAT 05-01-2025
- MLCO 05-08-2025
- Dividend Yield
- LMAT 0.99%
- MLCO N/A
- EPS Growth
- LMAT 30.45
- MLCO N/A
- EPS
- LMAT 1.97
- MLCO 0.14
- Revenue
- LMAT $226,256,000.00
- MLCO $4,758,114,000.00
- Revenue This Year
- LMAT $11.00
- MLCO $8.32
- Revenue Next Year
- LMAT $8.48
- MLCO $4.04
- P/E Ratio
- LMAT $40.86
- MLCO $41.06
- Revenue Growth
- LMAT 13.19
- MLCO 14.07
- 52 Week Low
- LMAT $71.42
- MLCO $4.55
- 52 Week High
- LMAT $109.58
- MLCO $8.90
- Technical
- Relative Strength Index (RSI)
- LMAT 39.99
- MLCO 71.35
- Support Level
- LMAT $78.01
- MLCO $4.95
- Resistance Level
- LMAT $83.51
- MLCO $6.09
- Average True Range (ATR)
- LMAT 3.21
- MLCO 0.24
- MACD
- LMAT -0.88
- MLCO 0.12
- Stochastic Oscillator
- LMAT 14.87
- MLCO 92.31
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.